跳至主要内容
临床试验/NCT01759316
NCT01759316已完成不适用

Nasal Intermittent Positive Pressure Ventilation and Mechanical Ventilation With Heliox in Preterm Infants With Respiratory Distress Syndrome

Third Military Medical University2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
length of ventilation and risk of mechanical ventilation

研究概览

简要总结

Heliox can lower respiratory resistance, improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation.

详细描述

Heliox can improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation.

Heliox has not been widely used. More studies on the effects and safety of Heliox in addition to NIPPV and mechanical ventilation should be tried.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
28 Weeks 至 37 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Gestational age more than 28 weeks and less than 32 weeks
  • Diagnosed as respiratory distress syndrome
  • Need to use NIPPV ventilation
  • No congenital diseases or hereditary diseases
  • With an informed consent form

排除标准

  • With congenital diseases or hereditary diseases
  • Intubated in the delivery room
  • Need surgery

结局指标

主要结局

length of ventilation and risk of mechanical ventilation

时间窗: participants will be followed for the duration of hospital stay, an expected average of 2 weeks

The primary outcome is the length of ventilation and risk of mechanical ventilation of participants.

次要结局

  • Transcutaneous blood gas analysis,ventilator parameters and lung inflammation cytokines(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuan Shi

Director, Head of Pediatrics, Principal Investigator, Clinical Professor

Third Military Medical University

研究点 (2)

Loading locations...

相似试验